AI Risk Scores Boost Dermatologists' Accuracy On Suspicious Lesions. It Supports. It Does Not Replace. Naturally.
A large retrospective reader study showed that a deep learning AI risk score, based on dermoscopic images and metadata, significantly improved experienced dermatologists' diagnostic accuracy and management strategies for suspicious skin lesions. The same report notes that administrative AI tools, specifically ambient scribes and revenue cycle management platforms, are seeing rapid real-world adoption in dermatology practices.
This validates the Augmentation Principle over the Automation Fallacy, a distinction your average tech journalist still cannot grasp. The mechanism is decision-support: AI narrows uncertainty for the human expert rather than replacing the expert entirely. The lesson generalizes well beyond dermatology. AI works best as a second opinion, not a first and final one.
Yesil Science published this finding in their August 2026 Dermatology AI Report, citing a large retrospective reader study where experienced dermatologists used dermoscopy-based AI risk scoring. The report also tracks adoption of ambient scribes and revenue cycle management AI tools in clinical dermatology settings.
- Search for a consumer mole or skin lesion tracking app that uses AI photo analysis, many are available in standard app stores.
- Photograph a mole or skin mark you want monitored and run it through the app's risk assessment feature.
- Regardless of what the app reports, schedule an appointment with a dermatologist for a professional evaluation. The expected outcome is that you experience AI as a screening prompt, not a diagnosis, which is exactly how it should function.